Cowen And Company, LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 07, 2024	BUY	$113.33 - $163.85 $781,977 - $1.13 Million	6,900 New	6,900 $1.09 Million
Q2 2022 Aug 05, 2022	SELL	$62.69 - $88.44 $752,280 - $1.06 Million	-12,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $524,145 - $750,486	8,300 Added 224.32%	12,000 $170,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $244,089 - $342,176	3,700 New	3,700 $32,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $1.91 Million - $3.52 Million	-20,500 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $24,714 - $39,491	300 Added 1.49%	20,500 $615,000
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $1.55 Million - $2.74 Million	20,200 New	20,200 $351,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.